Merck's Isentress Gets Boost From Guidelines Calling For Earlier HIV Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
International AIDS Society-USA recommendations reinforce trend toward early use of antiretrovirals.
You may also be interested in...
ViiV Preps Once-Daily Integrase Inhibitor '572 For Phase III
Phase II results presented at International AIDS Society meeting fuel speculation about co-formulations with other HIV drugs, including ViiV's Epzicom and Gilead's Truvada.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.